Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Leukemia, Lymphocytic

pyrrolidine dithiocarbamate has been researched along with Leukemia, Lymphocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Assreuy, J; Sampaio de Freitas, M; Santos-Silva, MC	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Leukemia, Lymphocytic

Article	Year
Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity. Cancer letters, 2001, Nov-08, Volume: 173, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Leukemia L1210; Leukemia, Lymphoid; Mice; Molsidomine; NF-kappa B; Nitric Oxide; Nitric Oxide Donors; Paclitaxel; Penicillamine; Protein Synthesis Inhibitors; Pyrrolidines; Thiocarbamates; Tumor Cells, Cultured	2001

Article

Year

Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-kappaB activity.

Cancer letters, 2001, Nov-08, Volume: 173, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Leukemia L1210; Leukemia, Lymphoid; Mice; Molsidomine; NF-kappa B; Nitric Oxide; Nitric Oxide Donors; Paclitaxel; Penicillamine; Protein Synthesis Inhibitors; Pyrrolidines; Thiocarbamates; Tumor Cells, Cultured

2001